Search Results 421-430 of 16955 for Cysteamine

  1. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. Phase I Dose Escalation: To investigate the MTD, safety, efficacy and pharmacokinetics of volasertib in combination with decitabine in ...

  3. Longitudinal Characterization and Genetic Analysis of Pediatric-Onset Morphea - Mayo Clinic

    About this study. The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of ...

  4. Education and Training - Mayo Clinic Research

    Learn about educational opportunities in Mayo Clinic's Epigenetic Etiology of Human Disease Laboratory of Keith D. Robertson, Ph.D., in Minnesota.

  5. ATHNdataset Registry - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Primary Sclerosing Cholangitis (PSC) Clinical Trials - Mayo Clinic Research

    This is a single-arm, open label, proof of concept (PoC) study of Cenicriviroc (CVC) in adult subjects with Primary Sclerosing Cholangitis (PSC). The main ...

  7. Gastroenterology and Hepatology - Clinical trials

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  8. Amcinonide (topical application route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Ointment; Cream; Lotion. Back to top ...

  9. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    About this study. The primary objective of this program is to provide Daclatasvir (DCV) for 24 weeks to be given in combination with Sofosbuvir (SOF) to ...

  10. A Study to Evaluate Firstline Pembrolizumab Alone or in Combination with Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients with Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...